Erste Asset Management Gmb H Biotechnology

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VCYT Veracyte, Inc.	$2.65B	$574 Million 0.01% of portfolio	17,000	Q3 2024 New
BEAM Beam Therapeutics Inc.	$1.85B	$544 Million 0.01% of portfolio	21,700	Q3 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$1.95B	$513 Million 0.01% of portfolio	13,100	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$1.15B	$464 Million 0.01% of portfolio	22,100	Q3 2024 New
LGND Ligand Pharmaceuticals Inc	$1.95B	$419 Million 0.01% of portfolio	4,300	Q3 2024 New
GLPG Galapagos Nv	$1.84B	$410 Million 0.0% of portfolio	14,000	Q3 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.28B	$397 Million 0.0% of portfolio	12,300	Q3 2024 New
ZLAB Zai Lab LTD	$2.61B	$357 Million 0.0% of portfolio	15,100	Q3 2024 New
IOVA Iovance Biotherapeutics, Inc.	$1.36B	$327 Million 0.0% of portfolio	34,000	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$670M	$325 Million 0.0% of portfolio	14,000	Q3 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.39B	$305 Million 0.0% of portfolio	40,000	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$684M	$239 Million 0.0% of portfolio	28,400	Q3 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.25B	$234 Million 0.0% of portfolio	33,500	Q3 2024 New
VIR Vir Biotechnology, Inc.	$1.15B	$217 Million 0.0% of portfolio	28,800	Q3 2024 New
KURA Kura Oncology, Inc.	$1.1B	$215 Million 0.0% of portfolio	11,000	Q3 2024 New
SAGE Sage Therapeutics, Inc.	$319M	$208 Million 0.0% of portfolio	28,500	Q3 2024 New
ADPT Adaptive Biotechnologies Corp	$797M	$179 Million 0.0% of portfolio	35,700	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$673M	$172 Million 0.0% of portfolio	23,100	Q3 2024 New
SANA Sana Biotechnology, Inc.	$493M	$171 Million 0.0% of portfolio	40,000	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$787M	$162 Million 0.0% of portfolio	62,000	Q3 2024 New
RGNX Regenxbio Inc.	$482M	$140 Million 0.0% of portfolio	13,000	Q3 2024 New
REPL Replimune Group, Inc.	$562M	$133 Million 0.0% of portfolio	11,900	Q3 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$598M	$104 Million 0.0% of portfolio	11,100	Q3 2024 New
AVXL Anavex Life Sciences Corp.	$626M	$102 Million 0.0% of portfolio	18,000	Q3 2024 New
ALEC Alector, Inc.	$405M	$93.5 Million 0.0% of portfolio	19,000	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$354M	$91.4 Million 0.0% of portfolio	31,400	Q3 2024 New
LYEL Lyell Immunopharma, Inc.	$273M	$81.5 Million 0.0% of portfolio	54,000	Q3 2024 New
VERV Verve Therapeutics, Inc.	$322M	$56.3 Million 0.0% of portfolio	11,300	Q3 2024 New
NKTR Nektar Therapeutics	$219M	$54.8 Million 0.0% of portfolio	46,800	Q3 2024 New
EDIT Editas Medicine, Inc.	$190M	$52.2 Million 0.0% of portfolio	15,000	Q3 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$225M	$36.8 Million 0.0% of portfolio	9,800	Q3 2024 New
NKTX Nkarta, Inc.	$131M	$32.5 Million 0.0% of portfolio	7,200	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$127M	$27.5 Million 0.0% of portfolio	13,900	Q3 2024 New
TSVT 2seventy Bio, Inc.	$148M	$24.6 Million 0.0% of portfolio	4,999	Q3 2024 New
BNTX Bio N Tech Se	$25.1B	$0 0.0% of portfolio	0	Q3 2024 New
TECH Bio Techne Corp	$2.85B	$0 0.0% of portfolio	0	Q3 2024 New
MRNA Moderna, Inc.	$15.6B	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.